Author

B. D. Piening

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. A. Al-Qurain· 1 shared A. AlAli· 1 shared A. F. Almuhanna· 1 shared A. H. Al Eleq· 1 shared A. Hamada· 1 shared A. I. Al-Sultan· 1 shared A. Jones· 1 shared A. k. Dodwell· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. Al-Qurain

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

D. A. Knorr, R. Leidner, S. Jensen, R. Meng, A. Jones, C. Ballesteros-Merino, R. B. Bell, M. Baez, D. Sprott, C. Bifulco, B. D. Piening, R. Dahan, B. Fox, J. Ravetch

This paper identifies FcyRIIB as an inhibitory Fc receptor limiting Treg depletion by anti-CTLA-4 antibodies and shows Fc engineering can enhance their efficacy.

bioRxiv · Jan 19, 2023 · PreprintImmunology

A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics

N. Iwamoto, Y. Koguchi, K. Yokoyama, A. Hamada, A. Yonezawa, B. D. Piening, E. Tran, B. A. Fox, W. L. Redmond, T. Shimada

This paper introduces a rapid and universal LC-MS-based platform for quantifying monoclonal antibodies, offering a scalable alternative to traditional ligand binding assays.

bioRxiv · Apr 22, 2022Immunology

Gut microbiota analyses of Saudi populations for type 2 diabetes-related phenotypes reveals significant association

A. AlAli, F. A. Al-Muhanna, A. k. Dodwell, A. H. Al Eleq, A. M. Al-Rubaish, W. I. Albaker, A. I. Al-Sultan, K. R. Alkharsah, R. M. Sulaiman, A. A. Al-Qurain, C. K. Cyrus, R. A. AlAli, C. Vatte, F. L. Robinson, C. Nguyen, , B. D. Piening

The paper analyzes gut microbiota in Saudi populations to identify associations with type 2 diabetes, finding increased Firmicutes abundance and a higher Firmicutes/Bacteroidetes ratio in diabetics.

bioRxiv · Oct 25, 2021Microbiology